Successful canakinumab treatment identifies IL-1beta as a pivotal mediator in Schnitzler syndrome.

Fulltext present in this item

Fulltext: 98374.pdf

Format: PDF

Description: publisher's version

Embargo: until further notice

Title:	Successful canakinumab treatment identifies IL-1beta as a pivotal mediator in Schnitzler syndrome.
Author(s):	Koning, H.D. de ; Schalkwijk, J. ; Meer, J.W.M. van der ; Simon, A.
Publication year:	2011
Source:	Journal of Allergy and Clinical Immunology, vol. 128, iss. 6, (2011), pp. 1352-1354
ISSN:	0091-6749
DOI:	http://dx.doi.org/10.1016/j.jaci.2011.05.023
Annotation:	1 december 2011
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/98374
Display more details
Subject:	N4i 1: Pathogenesis and modulation of inflammation NCMLS 1: Infection and autoimmunity
Organization:	Dermatology Internal Medicine
Journal title:	Journal of Allergy and Clinical Immunology
Volume:	vol. 128
Issue:	iss. 6
Page start:	p. 1352
Page end:	p. 1354

Faculty of Medical Sciences [73873]
Electronic publications [87075]
Freely accessible full text publications plus those not yet available due to embargo
Academic publications [187595]
Academic output Radboud University